4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001669866-26-000007
CEO AND PRESIDENT acquired 65,292 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Garcia Marino CEO AND PRESIDENT | 2026-03-16 | Option exercise | +59,700 | $6.70 | $399,990 | 59,700 | D: show line 1 in the form |
| Garcia Marino CEO AND PRESIDENT | 2026-03-16 | Option exercise | +5,592 | $17.88 | $99,985 | 65,292 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Garcia Marino CEO AND PRESIDENT | 2026-03-16 | Option exercise · Stock Option (Right to Buy) | −59,700 | 41 | D: show line 3 in the form | ||
| Garcia Marino CEO AND PRESIDENT | 2026-03-16 | Option exercise · Stock Option (Right to Buy) | −5,592 | 269,408 | D: show line 4 in the form |
Loading xslF345X05/ownership.xml…